Research on the application of graphene (G) and graphene quantum dots (GQDs) for biomedical engineering has attracted much attention over the last decade. Graphene and its derivatives have shown great biocompatibility, solubility, selectivity, large surface area, high purity, biofunctionalization, high drug loading capacity, and cell membrane penetration capability potential to be applied in biomedical engineering areas. The unique physical and chemical properties of GQDs, including small size, chemical inertness, high photoluminescence stability, low cytotoxicity, and good biocompatibility, made them a promising candidate for biomedical engineering applications. The recent progress related to the development of G and GQDs toward biomedical engineering applications is presented in this work. This study reviews and discusses the development of G and GQDs, both top-down and bottom-up synthesis methods, for biomedical engineering applications, such as biosensing, tissue engineering, drug delivery, bioimaging, antibacterial, and antiviral.
1 October 2020 in Proceeding of the Electrical Engineering Computer Science and Informatics
Cardiac troponin I (cTnI) is a cardiac biomarker for diagnosing ischemic heart disease and acute myocardial infarction. Current biochemical assays use antibodies (Abs) due to their high specificity and sensitivity. However, there are some limitations, such as the high-cost production of Abs due to complex instruments, reagents, and steps; the variability of Abs quality from batch to batch; the low stability at high temperatures; and the difficulty of chemical modification. Aptamer overcomes the limitations of antibodies, such as relatively lower cost, high reproducibility, high stability, and ease of being chemically modified. Aptamers are three-dimensional architectures of single-stranded RNA or DNA that bind to targets such as proteins. Six aptamers (Tro1-Tro6) with higher binding affinity than an antibody have been identified, but the molecular interaction has not been studied. In this study, six DNA aptamers were modeled and docked to cTnI protein. Molecular docking revealed that the interaction between all aptamer and cTnI happened in the similar cTnI region. The interaction between aptamer and cTnI involved hydrophobic interaction, hydrogen bonds, π-cation interactions, π-stack interactions, and salt-bridge formation. The calculated binding energy of all complexes was negative, which means that the complex formation was thermodynamically favorable. The electrostatic energy term was the main driving force of the interaction between all aptamer and cTnI. This study could be used to predict the behavior of further modified aptamer to improve aptamer performance.
Aptamers are single-stranded DNA or RNA that bind to specific targets such as proteins, thus having similar characteristics to antibodies. It can be synthesized at a lower cost, with no batch-to-batch variations, and is easier to modify chemically than antibodies, thus potentially being used as therapeutic and biosensing agents. The current method for RNA aptamer identification in vitro uses the SELEX method, which is considered inefficient due to its complex process. Computational models of aptamers have been used to predict and study the molecular interaction of modified aptamers to improve affinity. In this study, we generated three-dimensional models of five RNA aptamers from their sequence using mFold, RNAComposer web server, and molecular dynamics simulation. The model structures were then evaluated and compared with the experimentally determined structures. This study showed that the combination of mFold, RNAComposer, and molecular dynamics simulation could generate 14-16, 28, or 29 nucleotides length of 3D RNA aptamer with similar geometry and topology to the experimentally determined structures. The non-canonical basepair structure of the aptamer loop was formed through the MD simulation, which also improved the three-dimensional RNA aptamers model. Clustering analysis was recommended to choose the more representative model.
Losing a hand can significantly impact an individual’s physical and emotional well-being. Prosthetic hands can help restore some function and independence for individuals who have lost a hand. However, the prosthetic hands available on the market are prohibitively expensive, especially for developing countries, such as Indonesia. Commercial electronically powered prosthetic hands can be expensive, having prices ranging from $25,000 to $75,000 and annual maintenance costs ranging from $500 to $3000. In contrast, body-powered prosthetic hands are generally cheaper, ranging from $2000 to $10,000, but are still considered expensive for many people in developing countries. To make prosthetic hands more accessible, we have designed a body-powered prosthetic hand, “Karla”, using affordable materials and with as few components as possible. This report presents our proposed designs, the innovations, the parts in detail, and experiences using the designed prosthetic hand. The highlight of our design is a novel whippletree-like mechanism that utilizes the 3-D space to contract the fingers of the prosthetic hand.
In recent years, measuring and monitoring analyte concentrations continuously, frequently, and periodically has been a vital necessity for certain individuals. We developed a cotton-based millifluidic fabric-based electrochemical device (mFED) to monitor glucose continuously and evaluate the effects of mechanical deformation on the device’s electrochemical performance. The mFED was fabricated using stencil printing (thick film method) for patterning the electrodes and wax-patterning to make the reaction zone. The analytical performance of the device was carried out using the chronoamperometry method at a detection potential of −0.2 V. The mFED has a linear working range of 0–20 mM of glucose, with LOD and LOQ of 0.98 mM and 3.26 mM. The 3D mFED shows the potential to be integrated as a wearable sensor that can continuously measure glucose under mechanical deformation.